Victoria Kyrychenko
Affiliations: | University of Texas Southwestern Medical Center, Dallas, TX, United States |
Google:
"Victoria Kyrychenko"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Zhang QJ, Tran TAT, Wang M, et al. (2018) Histone lysine dimethyl-demethylase KDM3A controls pathological cardiac hypertrophy and fibrosis. Nature Communications. 9: 5230 |
Long C, Li H, Tiburcy M, et al. (2018) Correction of diverse muscular dystrophy mutations in human engineered heart muscle by single-site genome editing. Science Advances. 4: eaap9004 |
Parra VM, Altamirano F, Hernández-Fuentes CP, et al. (2018) Down Syndrome Critical Region 1 Gene, Rcan1, Helps Maintain a More Fused Mitochondrial Network. Circulation Research |
Kang C, Badr MA, Kyrychenko V, et al. (2017) Deficit in PINK1-PARKIN mediated mitochondrial autophagy at late stages of dystrophic cardiomyopathy. Cardiovascular Research |
Kyrychenko V, Kyrychenko S, Tiburcy M, et al. (2017) Functional correction of dystrophin actin binding domain mutations by genome editing. Jci Insight. 2 |
Gonzalez JP, Kyrychenko S, Kyrychenko V, et al. (2016) Small Fractions of Muscular Dystrophy Embryonic Stem Cells Yield Severe Cardiac and Skeletal Muscle Defects in Adult Mouse Chimeras. Stem Cells (Dayton, Ohio) |
Morales CR, Li DL, Pedrozo Z, et al. (2016) Inhibition of class I histone deacetylases blunts cardiac hypertrophy through TSC2-dependent mTOR repression. Science Signaling. 9: ra34 |
Li DL, Wang ZV, Ding G, et al. (2016) Doxorubicin Blocks Cardiomyocyte Autophagic Flux by Inhibiting Lysosome Acidification. Circulation |
Long C, Li H, Kyrychenko V, et al. (2016) 730. Permanent Correction of Diverse Muscular Dystrophy Mutations in Human Cardiomyocytes by Myoediting Molecular Therapy. 24: S288 |
Kyrychenko S, Kyrychenko V, Badr MA, et al. (2015) Pivotal role of miR-448 in the development of ROS-induced cardiomyopathy. Cardiovascular Research |